Authors:
ZUCCHETTI M
BOIARDI A
SILVANI A
PARISI I
PICCOLROVAZZI S
DINCALCI M
Citation: M. Zucchetti et al., DAUNORUBICIN AND DAUNORUBICINOL LEVELS IN HUMAN GLIOMA TUMORS AFTER ADMINISTRATION OF LIPOSOMAL ENCAPSULATED DAUNORUBICIN (DAUNOXOME), Annals of oncology, 9, 1998, pp. 617-617
Citation: A. Pozzi et al., NEW TRENDS IN THE MANAGEMENT OF PRIMARY CEREBRAL NON-HODGKINS-LYMPHOMA (PCNSL), Italian journal of neurological sciences, 19(1), 1998, pp. 53-54
Authors:
LAMANTIA L
POLLO B
SAVOIARDO M
COSTA A
EOLI M
ALLEGRANZA A
BOIARDI A
CESTARI C
Citation: L. Lamantia et al., MENINGO-CORTICAL CALCIFYING ANGIOMATOSIS AND CELIAC-DISEASE, Clinical neurology and neurosurgery, 100(3), 1998, pp. 209-215
Citation: A. Boiardi et A. Silvani, PRIMARY CEREBRAL NON-HODGKINS-LYMPHOMA (PCNSL) - A REVIEW OF NEW TRENDS IN MANAGEMENT, Italian journal of neurological sciences, 18(1), 1997, pp. 1-7
Authors:
SALMAGGI A
LUKSCH R
FORNO MG
POZZI A
SILVANI A
BOIARDI A
GASPARINI M
NEMNI R
Citation: A. Salmaggi et al., ANTINEURONAL ANTIBODIES IN PATIENTS WITH NEUROBLASTOMA - RELATIONSHIPS WITH CLINICAL-FEATURES, Tumori, 83(6), 1997, pp. 953-957
Authors:
SALMAGGI A
NEMNI R
POZZI A
SILVANI A
FORNO MG
LUKSCH R
CONFALONIERI P
BOIARDI A
Citation: A. Salmaggi et al., ANTINEURONAL ANTIBODY IN A PATIENT WITH NEUROBLASTOMA AND OPSOCLONUS-MYOCLONUS-ATAXIA - A CASE-REPORT, Tumori, 83(3), 1997, pp. 709-711
Authors:
BOIARDI A
SILVANI A
POZZI A
FARINOTTI M
FARISELLI L
BROGGI G
SALMAGGI A
Citation: A. Boiardi et al., ADVANTAGE OF TREATING ANAPLASTIC GLIOMAS WITH AGGRESSIVE PROTOCOL COMBINING CHEMOTHERAPY AND RADIOTHERAPY, Journal of neuro-oncology, 34(2), 1997, pp. 179-185
Authors:
SALMAGGI A
DUFOUR A
SILVANI A
CIUSANI E
NESPOLO A
BOIARDI A
Citation: A. Salmaggi et al., INTRATHECAL IMMUNOTHERAPY IN CNS TUMORS DISSEMINATING VIA CSF - PRELIMINARY EVALUATION USING DIFFERENT TREATMENT SCHEDULES, Italian journal of neurological sciences, 17(4), 1996, pp. 267-276
Authors:
BOIARDI A
SALMAGGI A
POZZI A
BROGGI G
SILVANI A
Citation: A. Boiardi et al., INTERSTITIAL CHEMOTHERAPY WITH MITOXANTRONE IN RECURRENT MALIGNANT GLIOMA - PRELIMINARY DATA, Journal of neuro-oncology, 27(2), 1996, pp. 157-162
Citation: Ar. Giovagnoli et A. Boiardi, COGNITIVE IMPAIRMENT AND QUALITY-OF-LIFE IN LONG-TERM SURVIVORS OF MALIGNANT BRAIN-TUMORS, Italian journal of neurological sciences, 15(9), 1994, pp. 481-488
Authors:
BOIARDI A
SILVANI A
RUFFINI PA
RIVOLTINI L
PARMIANI G
BROGGI G
SALMAGGI A
Citation: A. Boiardi et al., LOCO-REGIONAL IMMUNOTHERAPY WITH RECOMBINANT INTERLEUKIN-2 AND ADHERENT LYMPHOKINE-ACTIVATED KILLER-CELLS (A-LAK) IN RECURRENT GLIOBLASTOMAPATIENTS, Cancer immunology and immunotherapy, 39(3), 1994, pp. 193-197
Authors:
PEREGO P
BOIARDI A
CARENINI N
DECESARE M
DOLFINI E
GIARDINI R
MAGNANI I
MARTIGNONE S
SILVANI A
SORANZO C
ZUNINO F
Citation: P. Perego et al., CHARACTERIZATION OF AN ESTABLISHED HUMAN, MALIGNANT, GLIOBLASTOMA CELL-LINE (GBM) AND ITS RESPONSE TO CONVENTIONAL DRUGS, Journal of cancer research and clinical oncology, 120(10), 1994, pp. 585-592
Authors:
SILVANI A
SALMAGGI A
PARMIANI G
BOIARDI A
Citation: A. Silvani et al., SUCCESSFUL ADOPTIVE IMMUNOTHERAPY WITH LYMPHOKINE-ACTIVATED KILLER-CELLS IN THE TREATMENT OF MEDULLOBLASTOMA DISSEMINATED VIA CEREBROSPINAL-FLUID - CASE-REPORT, Neurosurgery, 34(6), 1994, pp. 1078-1080
Authors:
RUFFINI PA
RIVOLTINI L
SILVANI A
BOIARDI A
PARMIANI G
Citation: Pa. Ruffini et al., FACTORS, INCLUDING TRANSFORMING GROWTH-FACTOR-BETA, RELEASED IN THE GLIOBLASTOMA RESIDUAL CAVITY, IMPAIR ACTIVITY OF ADHERENT LYMPHOKINE-ACTIVATED KILLER-CELLS, Cancer immunology and immunotherapy, 36(6), 1993, pp. 409-416
Authors:
BOIARDI A
SILVANI A
VALENTINI S
SALMAGGI A
ALLEGRANZA A
BROGGI G
Citation: A. Boiardi et al., CHEMOTHERAPY AS 1ST TREATMENT FOR PRIMARY MALIGNANT NON-HODGKINS-LYMPHOMA OF THE CENTRAL-NERVOUS-SYSTEM PRELIMINARY DATA, Journal of neurology, 241(2), 1993, pp. 96-100